Home Search

drug development - search results

If you're not happy with the results, please do another search
memory decline

Alzheimer’s drug slows memory decline in phase 3 trial

Henry Scowcroft from Alzheimer’s Research UK, argues that an Alzheimer’s drug, lecanemab, can slow memory decline in a phase 3 trial.
woman injecting tuberculosis drug

Tuberculosis drug regimens and their efficacies

Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses tuberculosis drug development.
Bees collecting honey in honeycomb

Healing benefits of honey offers alternative to antimicrobial drugs

According to researchers, the healing benefits of honey are so promising that the sweet substance may replace antimicrobial drugs.
woman injecting tuberculosis drug

Tuberculosis drug regimens and their efficacies

Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.
Woman picking up migraine drug in supermarket in order to try lose weight

Migraine drug can boost weight loss by suppressing appetite

Triptans, a commonly prescribed class of migraine drugs, can help with weight loss and treating obesity by suppressing appetite.
Dupuytren’s disease

Research reveals that anti-TNF drug reverses Dupuytren’s disease

A clinical trial at Oxford University has found that a drug used for rheumatoid arthritis can reverse Dupuytren’s disease, if taken early on.
biology of fear, KNT-127

Scientists invent drug that stops the biology of fear

Tokyo researchers reveal how the biology of fear works - potentially changing how PTSD and anxiety are treated in future.
mdr-tb treatment, USAID

Treating multi-drug resistant tuberculosis

Andrew Nunn, Professor of Epidemiology, Medical Research Council Clinical Trials Unit at UCL, describes the first phase 3 trial of a shortened treatment for MDR-TB.
dismantle crime, levelling up

Levelling Up promises £3 billion on drug enforcement

Neighbourhood crime is at the heart of the policy, with the UK promising to cut homicide, serious violence and more by 2030.
lung cancer recurrence, atezolizumab

Drug gives 34% protection against lung cancer recurrence

The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.
mutated als gene

New gene-silencing drug could help with ALS

New research suggests that in suppressing a mutated ALS gene, it may be possible to delay to onset of symptoms.
performance enhancing drugs

Performance enhancing drugs can induce eating disorders

A study finds that performance and appearance enhancing drugs are closely linked to eating disorder symptoms in the US - especially in college-age groups.
organic synthesis

Chemistry: Catalyst developments for organic synthesis

Prof Masahiro Kamitani from the Department of Chemistry at Kitasato University, Japan, introduces recent advances in the development of catalysts for organic synthesis and iron catalysts as alternatives for precious metal catalysts.
Department of Physics, Faculty of Science and Technology - Chuo University

In scilico drug repositioning targeting SARS-CoV-2

Development of effective drugs toward COVID-19 is urgently required, and so research is being implemented with in scilico drug repositioning.
first malaria vaccine

Malaria deaths reduced by 70% with vaccine and drug combination

A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.
understand autism

Using human models of brain development to understand autism

Dr Kristen Kroll from Washington University School of Medicine discusses new approaches for studying autism and other neurodevelopmental disorders by using human cellular models of brain development.
Remdesivir

Combination of remdesivir and hep C drugs effective against COVID-19

A combination of remdesivir and drugs for hepatitis C virus (HCV) have presented strong effectiveness against COVID-19 in a new study.
psychiatric disorders

The changing perspective of psychedelic drugs with a history of abuse

Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
artificial tear substitutes, dry eye

Polymers and polymer-based drug delivery in the treatment of dry eye disease

Professor Heather Sheardown, C20/20 Ophthalmic Materials Innovation Hub, Department of Chemical Engineering, McMaster University, explores how polymers can be used to treat dry eye disease.
COVID in elderly patients, lung

Existing drugs could be used to fight COVID-19 in elderly patients

A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.

Follow Open Access Government